Literature DB >> 7859214

Treatment of canine sarcoptic mange using milbemycin oxime.

C de Jaham1, C J Henry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7859214      PMCID: PMC1687217     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


× No keyword cloud information.
  5 in total

1.  Effects of milbemycin oxime on adult hookworms in dogs with naturally acquired infections.

Authors:  D D Bowman; R C Johnson; D I Hepler
Journal:  Am J Vet Res       Date:  1990-03       Impact factor: 1.156

2.  Survival and infectivity of Sarcoptes scabiei var. canis and var. hominis.

Authors:  L G Arlian; R A Runyan; S Achar; S A Estes
Journal:  J Am Acad Dermatol       Date:  1984-08       Impact factor: 11.527

3.  Effects of milbemycin on adult Toxocara canis in dogs with experimentally induced infection.

Authors:  D D Bowman; J C Parsons; R B Grieve; D I Hepler
Journal:  Am J Vet Res       Date:  1988-11       Impact factor: 1.156

4.  Clinical efficacy of milbemycin oxime in the treatment of generalized demodicosis in adult dogs.

Authors:  W H Miller; D W Scott; J R Wellington; R Panić
Journal:  J Am Vet Med Assoc       Date:  1993-11-15       Impact factor: 1.936

5.  Clinical observations in collies given ivermectin orally.

Authors:  A J Paul; W J Tranquilli; R L Seward; K S Todd; J A DiPietro
Journal:  Am J Vet Res       Date:  1987-04       Impact factor: 1.156

  5 in total
  3 in total

1.  Topical (pour-on) ivermectin in the treatment of canine scabies.

Authors:  M Paradis; C de Jaham; N Pagé
Journal:  Can Vet J       Date:  1997-06       Impact factor: 1.008

2.  Treatment of canine scabies with milbemycin oxime.

Authors:  W H Miller; C de Jaham; D W Scott; S M Cayatte; M S Bagladi; R G Buerger
Journal:  Can Vet J       Date:  1996-04       Impact factor: 1.008

3.  Selamectin Is the Avermectin with the Best Potential for Buruli Ulcer Treatment.

Authors:  Nicole Scherr; Gerd Pluschke; Charles J Thompson; Santiago Ramón-García
Journal:  PLoS Negl Trop Dis       Date:  2015-08-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.